Missing mapped elements (Davide's email July 26th)

[gcangioli]

From Davide's email, July 26th

non riusciamo a trovare alcuni campi sulla documentazione.

• [ ] Diagnosi

  • [ ] “Altri quadri clinici, non associati al tumore”

• [x] Recidiva/Progressione (prima della prima fine elettiva delle cure)/ Recidiva/progressione (AFTER):

  • [x] “Tipo” (locale, distante, combinata)
  • [x] “Se distante, sede delle metastasi” (testo libero)

• [x] Chirurgia maggiore

  • [x] “Se si, descrivere la protesi” (interna/esterna)

• [x] Chemioterapia

  • [x] Il tipo di dose (dose cumulativa somministrata/stimata/non noto)
  • [x] "I dosaggi indicati sono incompleti" (direttamente connesso al campo "Steroidi ad alte dosi continuative per più di quattro settimane?")
  • [x] “Motivazioni” campo di testo collegato a “I dosaggi indicati sono incompleti”

• [ ] Non abbiamo indicazioni sulla scheda "Medical suggestion" (now moved to #37 )

[gcangioli]

• [ ] Diagnosi
  • [ ] “Altri quadri clinici, non associati al tumore”

See https://github.com/hl7-eu/pcsp/issues/35

[gcangioli]

• [x] Recidiva/Progressione (prima della prima fine elettiva delle cure)/ Recidiva/progressione (AFTER):

See https://github.com/hl7-eu/pcsp/issues/36

[gcangioli]

• [x] Major Surgery  
  • [x] If yes - Please define if prosthesis is internal (e.g. titanium bone) or external (e.g. artificial limb). Also in this case, details should be reported in the surgery description

See https://build.fhir.org/ig/hl7-eu/pcsp/StructureDefinition-MajorSurgery-definitions.html#MajorSurgery.prothesis.deviceType MajorSurgery.prothesis.deviceType , mapped into the usedCode

[gcangioli]

• [x] Chemioterapia

  • [x] Il tipo di dose (dose cumulativa somministrata/stimata/non noto)

See Chemotherapy.productAdministration.cumulativeDose.measureType mapped into Observation.method

• [x] "I dosaggi indicati sono incompleti"

See Chemotherapy.productAdministration.cumulativeDose.completionStatus mapped into Observation.status

• [x] “Motivazioni” campo di testo collegato a “I dosaggi indicati sono incompleti”

Chemotherapy.productAdministration.cumulativeDose.statusReason mapped into the statusReason extension

[gcangioli]

• [x] Non abbiamo indicazioni sulla scheda "Medical suggestion"

Documented into the medicalSuggestion section

[davisart]

• [x] Major Surgery  

  • [x] If yes - Please define if prosthesis is internal (e.g. titanium bone) or external (e.g. artificial limb). Also in this case, details should be reported in the surgery description

See https://build.fhir.org/ig/hl7-eu/pcsp/StructureDefinition-MajorSurgery-definitions.html#MajorSurgery.prothesis.deviceType MajorSurgery.prothesis.deviceType , mapped into the usedCode

• [x] please add "unknown"
• [x] fix external device description

[davisart]

• [x] Chemioterapia

  • [x] Il tipo di dose (dose cumulativa somministrata/stimata/non noto)

See Chemotherapy.productAdministration.cumulativeDose.measureType mapped into Observation.method

• [x] please add "unknown"

[davisart]

• [x] Non abbiamo indicazioni sulla scheda "Medical suggestion"

Documented into the medicalSuggestion section

• [ ] section appears as follow:

[gcangioli]

• [x] Non abbiamo indicazioni sulla scheda "Medical suggestion"

Documented into the medicalSuggestion section

This part seems not to be just textual, but a little structured (date of prescription, single text field with all the medications; other textual data).

@davisart : to be clarified if a textual export of this information could be enough at this stage, or if we need a more structured management of these data But may require to add more.

[davisart]

Medical Suggestion contains all medication prescribed that are not linked to tumors, in these cases each drug needs a date (not possible for now in the platform). Medical Suggestion will be covered by a new section "Follow Up" not yet present in the platform. Gaslini will tell us on how to proceed, in the meantime I suggest to skip this part

[davisart]

the same applies on "Altri quadri clinici, non associati al tumore"

[gcangioli]

remaining issues documented by #37 and #35